DataMEDS AI, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MEDS research report →
Price Chart
About the company
DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.
- CEO
- Prashant Patel
- IPO
- 2025
- Employees
- 31
- HQ
- Tampa, FL, US
Get TickerSpark's AI analysis on MEDS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $7.92M
- P/E
- -0.07
- PEG
- 0.00
- P/S
- 1.13
- P/B
- -0.46
- EV/EBITDA
- -0.70
- Div Yield
- 0.00%
- Gross Margin
- -125.11%
- Op Margin
- -719.27%
- Net Margin
- -1100.30%
- ROE
- 877.58%
- ROIC
- -439.90%
Latest fiscal year · YoY change
- Revenue
- $23.34M+28.7%
- Gross Profit
- $-9,637,483-645.3%
- Op Income
- $-81,194,831
- Net Income
- $-101,274,530-1377.1%
- EPS
- $-71.50-1000.0%
- OCF Growth
- -786.1%
- FCF Growth
- -577.5%
- 52W High
- $73.00
- 52W Low
- $0.82
- 50D MA
- $2.32
- 200D MA
- $7.32
- Beta
- -1.52
- RSI (14)
- 53
- Avg Volume
- 6.04M
No earnings-call transcripts are available for MEDS yet.
- Free Float
- —
- Shares Outstanding
- 3.06M
- Float Shares
- 1.05M
of shares held by institutions
11 13F filers
Held by 4 ETFs
Biggest fund positions in MEDS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 22, 26 | AJJARAPU SURENDRA K | other | 100,000 |
| Jun 22, 26 | AJJARAPU SURENDRA K | other | 100,000 |
| Jun 22, 26 | Patel Prashant | other | 100,000 |
| Jun 22, 26 | Patel Prashant | other | 100,000 |
| Mar 31, 26 | Patel Prashant | other | 5,000,000 |
| Mar 31, 26 | AJJARAPU SURENDRA K | other | 5,000,000 |
| Mar 31, 26 | Patel Prashant | other | 5,000,000 |
| Mar 31, 26 | Patel Prashant | other | 5,000,000 |
| Mar 31, 26 | AJJARAPU SURENDRA K | other | 5,000,000 |
| Mar 31, 26 | AJJARAPU SURENDRA K | other | 5,000,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MEDS coverage
Recent articles, reports, and earnings notes.
No research on MEDS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MEDS report →Datameds AI Files DBAs Datameds SI And Corexa Health SI And Reminds Shareholders Of Record As Of August 7, 2026 Of Dream Bowl Meme Coin I Payment
accessnewswire.com · Oct 5
DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue
accessnewswire.com · Oct 1
Wellgistics Health, Inc. (NASDAQ:MEDS) Stock Short Interest Rises 147.5%
defenseworld.net · Sep 29
DataMeds AI Stock Surges on Mobile App Launch
benzinga.com · Sep 28
DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application
accessnewswire.com · Sep 28
DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit
accessnewswire.com · Sep 25
DataMEDS AI Unveils New Corporate Website
accessnewswire.com · Sep 21
DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked
accessnewswire.com · Sep 18
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.